Arq. Bras. Oftalmol. 2022; 85 (1): 10.5935/0004-2749.20220003
Total: 2544
Michael Jay Schatz1; Brendan C. McGeehan2; Maureen G. Maguire2; César A. Briceño2
DOI: 10.5935/0004-2749.20220003
1. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
2. Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA
César A. Briceño
E-mail: [email protected]
Funding: This study received no specific financial support
Disclosure of potential conflicts of interest: Dr. Briceño is a consultant for Horizon Therapeutics. None of the other authors have financial interests related to this manuscript
How to cite this article: